Metabolic and Skeletal Effects of Low and High Doses of Calcium Acetate in Patients with Preterminal Chronic Renal Failure

2002 ◽  
Vol 22 (5-6) ◽  
pp. 445-454 ◽  
Author(s):  
Kenneth R. Phelps ◽  
Marc Stern ◽  
Alice Slingerland ◽  
Mahin Heravi ◽  
David S. Strogatz ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Calcium Acetate ◽  
Skeletal Effects ◽  
High Doses

High doses of mepivacaine for brachial plexus block in patients with end-stage chronic renal failure. A pilot study

2001 ◽  
Vol 18 (3) ◽  
pp. 171-176 ◽  
Author(s):  
J. Rodríguez ◽  
O. Quintela ◽  
M. López-Rivadulla ◽  
M. Bárcena ◽  
C. Diz ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Pilot Study ◽  
Brachial Plexus ◽  
Brachial Plexus Block ◽  
High Doses ◽  
End Stage ◽  
Plexus Block

Role of High-Dose Intravenous Frusemide Therapy in the Management of Chronic Renal Failure

1975 ◽  
Vol 3 (4) ◽  
pp. 245-250
Author(s):  
Mam Chandra ◽  
M K Mitra ◽  
N N Gupta
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Side Effects ◽  
Treated Group ◽  
Fixed Dose ◽  
High Dose ◽  
Dose Regime ◽  
Diuretic Response ◽  
High Doses

The results of using high doses of intravenous frusemide in the management of 28 patients suffering from chronic renal failure are presented. The results are compared with those obtained from 14 patients also suffering from chronic renal failure, who received identical ‘conservative management’ but were not treated with diuretics. Large doses of intravenous frusemide produced a satisfactory diuretic response in a higher percentage of treated patients (71%) compared with controls (36%). It was also observed that in the treated group of patients a significant diuretic response could be obtained in patients with a creatinine clearance below 4 ml per minute. The study also demonstrated that in the group of patients receiving frusemide the response was better in those who were given a progressive-dose regime; 88% of patients improved with this regime compared with 68% of patients who were treated with a fixed dose of frusemide. Transient deafness with tinnitus and vertigo were the only side-effects observed. However these effects were only seen in patients who received 1000 mg or more frusemide in one day, administered over a period of one to two hours. It is concluded that all patients suffering from chronic renal failure should be given a trial of large doses of intravenous frusemide therapy, along with other conventional measures, particularly where facilities for dialysis are not immediately available.

Serum 25-Hydroxyvitamin D in Patients with Chronic Renal Failure on Long-Term Treatment with High Doses of Vitamin D2

Nephron ◽  
1980 ◽  
Vol 26 (3) ◽  
pp. 116-120
Author(s):  
Peter Teodor Fröhling ◽  
Franciszek Kokot ◽  
Karl Vetter ◽  
Jadwiga Kuska ◽  
Ingrid Kaschube ◽  
...  
Keyword(s):  
Vitamin D ◽  
Renal Failure ◽  
Chronic Renal Failure ◽  
Term Treatment ◽  
Hydroxyvitamin D ◽  
Long Term Treatment ◽  
25 Hydroxyvitamin D ◽  
High Doses

Effects of High Doses of Frusemide on Plasma and Muscle Electrolytes in Patients with Chronic Renal Failure

Nephron ◽  
1974 ◽  
Vol 13 (3) ◽  
pp. 235-244 ◽  
Author(s):  
G. Maschio ◽  
G. Mioni ◽  
A. D’Angelo ◽  
E. Ossi ◽  
E. Valvo ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
High Doses

High doses of mepivacaine for brachial plexus block in patients with end-stage chronic renal failure. A pilot study

2001 ◽  
Vol 18 (3) ◽  
pp. 171-176 ◽  
Author(s):  
J. Rodriguez ◽  
O. Quintela ◽  
M. Lopez-Rivadulla ◽  
M. Barcena ◽  
C. Diz ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Pilot Study ◽  
Brachial Plexus ◽  
Brachial Plexus Block ◽  
High Doses ◽  
End Stage ◽  
Plexus Block

Sodium Conservation in Chronic Renal Failure: Studies Using Oral Diazoxide

1972 ◽  
Vol 43 (6) ◽  
pp. 771-778 ◽  
Author(s):  
J. D. Swales ◽  
H. Thurston ◽  
J. E. F. Pohl
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Transport Mechanism ◽  
Sodium Concentration ◽  
Urinary Sodium ◽  
Sodium Depletion ◽  
Osmotic Diuresis ◽  
Tubular Transport ◽  
High Doses ◽  
Osmotic Load

1. The defect in sodium conservation shown by patients with advanced chronic renal failure has been studied during the administration of diazoxide. 2. All nine patients showed a reduction in urinary sodium concentration to levels substantially lower than those which can normally be produced in such patients even with prolonged sodium depletion. Seven patients produced a nearly sodium-free urine. In all patients this effect could be reversed by the administration of high doses of frusemide. The fall in urinary sodium concentration was associated with a sustained fall in creatinine clearance in only two cases. 3. One patient with salt-losing renal disease showed a more modest fall in sodium concentration on treatment with diazoxide. 4. It is concluded that since the defect in sodium conservation shown by patients with chronic renal failure can be corrected without diminishing the osmotic load, it cannot be solely due to the effect of the osmotic diuresis upon residual functioning nephrons. It is suggested that the distal tubular transport mechanism for sodium is saturated by the increased delivery of sodium from the proximal tubule.

Mist pot CIT made palatable

1982 ◽  
Vol 20 (25) ◽  
pp. 100.2-100
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Potassium Citrate ◽  
Post Irradiation ◽  
Urinary Infections ◽  
High Doses

Potassium Citrate Mixture is sometimes used to make the urine alkaline but tastes unpleasant. Effervescent tablets (Effercitrate - Typharm) have recently been introduced as a palatable and more convenient alternative. One tablet contains the equivalent of 5 ml of the Mixture BPC 1973 (13.9 mmol potassium) in a lemon-flavoured effervescent base. Effercitrate may prove more acceptable than the mixture when urinary alkalinization is needed as in patients with post-irradiation cystitis,1 in certain urinary infections, and to prevent crystalluria during treatment with high doses of sulphonamides or methotrexate. Both preparations should be avoided in patients with chronic renal failure.

Calcium acetate versus calcium carbonate: Phosphate absorption studies in chronic renal failure

Nephrology ◽  
1996 ◽  
Vol 2 (1) ◽  
pp. 53-55 ◽  
Author(s):  
L JEGADEESAN ◽  
BS RAMAKRISHNA ◽  
George T JOHN ◽  
CK JACOB ◽  
JCM SHASTRY
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Calcium Carbonate ◽  
Calcium Acetate ◽  
Phosphate Absorption ◽  
Absorption Studies

scholarly journals Comparison of Three Formulations of Calcium Acetate Tablets to Evaluate Tolerance and Control of Hyperphosphatemia in Patients with Chronic Renal Failure

Nephron ◽  
1994 ◽  
Vol 68 (4) ◽  
pp. 505-506 ◽  
Author(s):  
J.P.W. van den Bergh ◽  
B.G. Kaufmann ◽  
G.J.A. van Riet ◽  
W.M. Böttger ◽  
V.M.C. Verstappen
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Calcium Acetate ◽  
And Control
Sign in / Sign up

Export Citation Format

Share Document